Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 4Thoracic 3Gynecologic 3Gastrointestinal 3Plasma cell 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Genitourinary 2Dermatologic 2CNS 2

Conditions

Colonic Neoplasms 2Pancreatic Ductal Adenocarcinoma 1

Interventions

Oxaliplatin 1413Fluorouracil 1301Capecitabine 1087Gemcitabine 1045Leucovorin 932Irinotecan 818Bevacizumab 804Cisplatin 669Radiotherapy 536Cetuximab 470pembrolizumab 428Paclitaxel 390Nivolumab 337130-nm albumin-bound paclitaxel 325Drug Therapy 314Docetaxel 287S 1 (combination) 274Sorafenib 266Folfox protocol 261Albumin-Bound Paclitaxel 259sintilimab 211durvalumab 210Surgical Procedures, Operative 204tislelizumab 203Radiosurgery 202lenvatinib 201apatinib 200Carboplatin 187Magnetic Resonance Spectroscopy 183regorafenib 181

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Glucose × Gastrointestinal × Clear all
NCT05296421 2026-05-04

Investigating Targetable Metabolic Pathways Sustaining Pancreatic Cancer

Rutgers, The State University of New Jersey

Phase NA Recruiting
16 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT02288611 2014-11-11

AJWA

University of Reading

Phase NA Completed
22 enrolled
Gastrointestinal

Colonic Neoplasms

NCT01222208 2012-02-07

Oral Versus Parenteral Nutrition Support to Improve Protein Balance in Colorectal Surgical Patients

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Completed
20 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡